Table 3.

Screening for antibacterial activities of actinobacterial isolate cell-free extracts. Data are represented by the means of at least 3 replicates ± standard deviations (SD).

Isolates	S. pneumonia	S. aureus	E. coli	B. cereus	E. faecalis	S. typhimurium	P. aeruginosa
Act 1	9.8 ± 0.6	11 ± 0.8	13 ± 0.9	14.4 ± 1	15.7 ± 1	17.5 ± 1.1	19.1 ± 1.2
Act 2	16.3 ± 1.3	21 ± 1.8	24 ± 2	27 ± 2.2	21 ± 2.9	25.2 ± 0.7	24.9 ± 1.6
Act 3	11.1 ± 0.6	13 ± 0.6	14 ± 0.6	15 ± 0.6	15 ± 0.6	15.6 ± 0.5	12.5 ± 0.6
Act 4	9.9 ± 0.8	12 ± 1.1	10 ± 1.5	12.6 ± 1	14 ± 2.8	18 ± 6.5	7.8 ± 2
Act 5	9.2 ± 0.6	10 ± 0.5	10 ± 0.5	7 ± 0.4	16 ± 0.9	21.5 ± 0.4	7.2 ± 0.4
Act 6	9.9 ± 0.7	10 ± 0.8	10 ± 0.8	10 ± 0.9	17 ± 2.5	10.1 ± 0.9	10.1 ± 0.9
Act 7	10.5 ± 0.7	12 ± 0.9	13 ± 0.9	14 ± 1.0	17 ± 2.4	15.1 ± 1.3	16 ± 1.5
Act 8	15.2 ± 1.2	13.6 ± 1	12.1 ± 1	10 ± 0.8	14 ± 1.4	7.7 ± 0.5	23.3 ± 5.2
Act 9	13.6 ± 0.9	12 ± 0.9	12 ± 0.9	12 ± 0.9	8 ± 1.2	10.8 ± 0.9	16.6 ± 3.4
Act 10	10.8 ± 0.7	8.1 ± 0.4	6 ± 0.4	11.1 ± 1	13 ± 2.4	11.9 ± 1.2	14.2 ± 1.6
Act 11	10.3 ± 0.7	10 ± 0.8	10 ± 0.9	10 ± 0.9	5.8 ± 1.8	12.7 ± 1.0	8.7 ± 1.3
Act 12	19.4 ± 1.6	20.2 ± 1	24 ± 0.5	29 ± 2.7	21 ± 4.5	22.50 ± 4	20.0 ± 2.5
Act 13	14.8 ± 0.8	18 ± 0.8	19 ± 0.8	15 ± 0.8	25 ± 1.2	19.8 ± 0.8	22.5 ± 1.8
Act 14	8.9 ± 0.5	13.4 ± 1	16 ± 1.3	17 ± 0.3	11 ± 3.7	15.6 ± 0.9	9.7 ± 3.7
Act 15	18.2 ± 1.5	24 ± 2.1	15 ± 5.1	29 ± 0.9	26 ± 4.1	27.2 ± 3.2	26.3 ± 3.7
Act 16	13 ± 0.6	17 ± 0.8	18 ± 0.9	21.4 ± 1	23 ± 1.1	22.8 ± 1.1	27.3 ± 1.7
Act 17	8.9 ± 0.6	10 ± 0.6	10 ± 0.6	10 ± 0.6	14 ± 1.1	9.70 ± 0.7	15.1 ± 1.4
Act 18	10.5 ± 0.8	12.5 ± 1	13 ± 1.1	14.5 ± 1	15 ± 0.8	17.1 ± 1.4	14 ± 0.8
Act 19	20.4 ± 1.4	26 ± 2.3	24 ± 0.6	28 ± 0.2	29 ± 2.8	26.0 ± 5.5	19.2 ± 2
Act 20	15.3 ± 0.7	16 ± 0.7	17 ± 0.7	18.0.7	14 ± 0.7	25.6 ± 0.6	12.8 ± 0.7
Act 21	16.9 ± 1.9	18 ± 0.7	20 ± 0.6	24.2 ± 1	22 ± 2.6	21.7 ± 1.1	23.5 ± 1.1